Urologische Klinik und Poliklinik » Forschung » Publikationen 2010

Publikationen 2010

[Surgical treatment for renal cell carcinoma].
Aktuelle Urol. 2010;41(4): 252-6
Roos FC, Rübben H, Stief C, Stöckle M, Thüroff JW

[Impact of immunotherapy in metastatic kidney cancer in Germany after introduction of new target therapy--results of a telephone survey of the German Society of Immuno- and Targeted Therapy (DGFIT)]
Aktuelle Urol. 2010;41(2): 122-30
Siebels M, Staehler M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H, Deutsche Gesellschaft für Immun- und Targeted Therapie e.V. (DGFIT)

Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population.
Andrologia. 2010;42(4): 218-24
Eisenhardt A, Stief C, Porst H, Wetterauer U, Weidner W, Rübben H, Sperling H

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy.
Ann Oncol. 2010; [Epub ahead of print]
Johannsen M, Staehler M, Ohlmann CH, Flörcken A, Schmittel A, Otto T, Bex A, Hein P, Miller K, Weikert S, Grünwald V

Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.
Anticancer Res. 2010;30(7): 2785-9
Hauser S, Zahalka T, Ellinger J, Fechner G, Heukamp LC, VON Ruecker A, Müller SC, Bastian PJ

Epithelial versus endothelial CEACAM1 expression and angiogenesis in epididymal adenomatoid tumor.
Anticancer Res. 2010;30(7): 2651-7
Kilic N, Tilki D, Ergün B, Seitz M, Stief CG, Reich O, Ergün S

Vascular wall as a reservoir for different types of stem and progenitor cells.
Antioxid Redox Signal. 2010; [Epub ahead of print]
Ergün S, Tilki D, Klein D

The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.
BJU Int. 2010;106(8): 1114-27
Andersson KE, Gratzke C, Hedlund P

Mid-term results for the retroluminar transobturator sling suspension for stress urinary incontinence after prostatectomy.
BJU Int. 2010; [Epub ahead of print]
Bauer RM, Soljanik I, Füllhase C, Karl A, Becker A, Stief CG, Gozzi C

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
BJU Int. 2010; [Epub ahead of print]
Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L

DNA hypermethylation in papillary renal cell carcinoma.
BJU Int. 2010; [Epub ahead of print]
Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Müller SC, Bastian PJ

Volar onlay urethroplasty for reconstruction of female urethra in recurrent stricture disease.
BJU Int. 2010; [Epub ahead of print]
Gozzi C, Roosen A, Bastian PJ, Karl A, Stief C, Tritschler S

Impact of previous mesh hernia repair on the performance of open radical prostatectomy - complications and functional outcome.
BJU Int. 2010;106(11): 1628-31
Hocaoglu Y, Bastian P, Buchner A, Bauer R, Bader M, Tritschler S, Stanislaus P, Stief C, Karl A

Evidence-based urology in practice: loss to follow-up.
BJU Int. 2010;106(1): 24-6
Karl A, Akl EA, Moy ML, Dahm P, Evidence-Based Urology Working Group

Effects of cavernous nerve reconstruction on expression of nitric oxide synthase isoforms in rats.
BJU Int. 2010; [Epub ahead of print]
Schlenker B, Matiasek K, Saur D, Gratzke C, Bauer RM, Herouy Y, Arndt C, Blesch A, Hartung R, Stief CG, Weidner N, May F

Organ-preserving neodymium-yttrium-aluminium-garnet laser therapy for penile carcinoma: a long-term follow-up.
BJU Int. 2010; [Epub ahead of print]
Schlenker B, Tilki D, Seitz M, Bader MJ, Reich O, Schneede P, Hungerhuber E, Stief CG, Gratzke C

Detection of urinary leakage after radical retropubic prostatectomy by contrast enhanced ultrasound - do we still need conventional retrograde cystography?
BJU Int. 2010; [Epub ahead of print]
Schoeppler GM, Buchner A, Zaak D, Khoder W, Staehler M, Stief CG, Reiser MF, Clevert DA

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
BJU Int. 2010;105(10): 1402-12
Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y

p53 expression in patients with advanced urothelial cancer of the urinary bladder.
BJU Int. 2010;105(4): 489-95
Shariat SF, Bolenz C, Karakiewicz PI, Fradet Y, Ashfaq R, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Rigaud J, Müller SC, Lerner SP, Montorsi F, Sagalowsky AI, Cote RJ, Lotan Y

Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
BJU Int. 2010; [Epub ahead of print]
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF

The growth rate of large renal masses opposes active surveillance.
BJU Int. 2010;105(7): 928-31
Staehler M, Haseke N, Stadler T, Zilinberg E, Nordhaus C, Nuhn P, Khoder WY, Karl A, Stief CG

Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma.
BJU Int. 2010; [Epub ahead of print]
Staehler M, Haseke N, Nuhn P, Tüllmann C, Karl A, Siebels M, Stief CG, Wowra B, Muacevic A

Influence of clinical information on the interpretation of urinary cytology in bladder cancer: how suggestible is a cytologist?
BJU Int. 2010; [Epub ahead of print]
Tritschler S, Karl A, Sommer ML, Straub J, Strittmatter F, Tilki D, Hocaoglu Y, Stief C, Zaak D

Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
BJU Int. 2010; [Epub ahead of print]
Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF

The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
Clin Cancer Res. 2010;16(17): 4461-7
Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Müller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP

Urinary incontinence in women: part 1 of a series of articles on incontinence.
Dtsch Arztebl Int. 2010;107(24): 420-6
Dannecker C, Friese K, Stief C, Bauer R

[Surgical treatment for renal cell carcinoma]
Dtsch Med Wochenschr. 2010;135(6): 245-9
Roos FC, Rübben H, Stief C, Stöckle M, Thüroff JW

Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET.
Eur J Cancer. 2010;46(13): 2432-40
Hutson TE, Bellmunt J, Porta C, Szczylik C, Staehler M, Nadel A, Anderson S, Bukowski R, Eisen T, Escudier B, Sorafenib TARGET Clinical Trial Group

Optical coherence tomography for bladder cancer -- ready as a surrogate for optical biopsy? Results of a prospective mono-centre study.
Eur J Med Res. 2010;15(3): 131-4
Karl A, Stepp H, Willmann E, Buchner A, Hocaoglu Y, Stief C, Tritschler S

Minimizing complications during retropubic radical prostatectomy - Is ureteral stenting necessary?
Eur J Med Res. 2010;15(3): 121-3
Schlenker B, Gratzke C, Seitz M, von Walter P, Tilki D, Reich O, Zaak D, Stief CG, Bader MJ

Comparison of guideline recommendations with daily practice in patients with renal cell carcinoma.
Eur J Med Res. 2010;15(6): 253-7
Schlenker B, Seitz M, Bader MJ, Ganzer R, Tilki D, Bayrle F, Reich O, Staehler M, Bachmann A, Stief CG, Gratzke C

Sorafenib after Combination Therapy with Gemcitabine plus Doxorubicine in Patients with Sarcomatoid Renal Cell Carcinoma: A Prospective Evaluation.
Eur J Med Res. 2010;15(7): 287-91
Staehler M, Haseke N, Roosen A, Stadler T, Bader M, Siebels M, Karl A, Stief CG

MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: Quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Eur J Radiol. 2010; [Epub ahead of print]
Scherr MK, Seitz M, Müller-Lisse UG, Ingrisch M, Reiser MF, Müller-Lisse UL

Delineation of upper urinary tract segments at MDCT urography in patients with extra-urinary mass lesions: retrospective comparison of standard and low-dose protocols for the excretory phase of imaging.
Eur Radiol. 2010; [Epub ahead of print]
Mueller-Lisse UL, Coppenrath EM, Meindl T, Degenhart C, Scherr MK, Stief CG, Reiser MF, Mueller-Lisse UG

Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.
Eur Urol. 2010;58(3): 384-97 [PDF]
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG

High-intensity focused ultrasound for localized prostate cancer: ready for prime time?
Eur Urol. 2010;58(4): 514-5; discussion 515-6 [PDF]
Bastian PJ

Reply from Authors re: Urs E. Studer, Laurence Collette, Richard Sylvester. Can Radical Prostatectomy Benefit Patients Despite the Presence of Regional Metastases? Eur Urol, in press.
Eur Urol. 2010;58: e43 [PDF]
Engel J, Bastian PJ, Gschwend JE, Stief CG, Hölzel D

Survival Benefit of Radical Prostatectomy in Lymph Node-Positive Patients with Prostate Cancer.
Eur Urol. 2010;57: 754-61 [PDF]
Engel J, Bastian PJ, Baur H, Beer V, Chaussy C, Gschwend JE, Oberneder R, Rothenberger KH, Stief CG, Hölzel D

Characteristics and outcomes of patients with clinical t1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
Eur Urol. 2010;57(2): 300-9 [PDF]
Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF

Editorial comment on: Surgical treatment of 31 complex traumatic posterior urethral strictures associated with urethrorectal fistulas.
Eur Urol. 2010;57(3): 520 [PDF]
Gozzi C, Tritschler S

Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.
Eur Urol. 2010;57(2): 342-8 [PDF]
Gratzke C, Christ GJ, Stief CG, Andersson KE, Hedlund P

Effects of Cannabinor, a Novel Selective Cannabinoid 2 Receptor Agonist, on Bladder Function in Normal Rats.
Eur Urol. 2010;57: 1093-1100 [PDF]
Gratzke C, Streng T, Stief CG, Downs TR, Alroy I, Rosenbaum JS, Andersson KE, Hedlund P

Transient Receptor Potential A1 and Cannabinoid Receptor Activity in Human Normal and Hyperplastic Prostate: Relation to Nerves and Interstitial Cells.
Eur Urol. 2010;57(5): 902-10 [PDF]
Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund P

Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
Eur Urol. 2010;57(6): 1064-71 [PDF]
Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF

What do we know (or think we know) about erectile dysfunction following laser treatments for lower urinary tract symptoms?
Eur Urol. 2010;58(2): 212-3 [PDF]
Reich O

Plasma Vaporisation of the Prostate: Initial Clinical Results.
Eur Urol. 2010;57: 693-98 [PDF]
Reich O, Schlenker B, Gratzke C, Tilki D, Riecken M, Stief C, Seitz M, Bachmann A

Long-term Follow-up of Bladder Cancer Patients with Disseminated Tumour Cells in Bone Marrow.
Eur Urol. 2010; [Epub ahead of print] [PDF]
Retz M, Rotering J, Nawroth R, Buchner A, Stöckle M, Gschwend JE, Lehmann J

Repeat Retrourethral Transobturator Sling in the Management of Recurrent Postprostatectomy Stress Urinary Incontinence After Failed First Male Sling.
Eur Urol. 2010;58: 767-72 [PDF]
Soljanik I, Becker AJ, Stief CG, Gozzi C, Bauer RM

Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome.
Eur Urol. 2010;58: 112-7 [PDF]
Tilki D, Reich O, Karakiewicz PI, Novara G, Kassouf W, Ergün S, Fradet Y, Ficarra V, Sonpavde G, Stief CG, Skinner E, Svatek RS, Lotan Y, Sagalowsky AI, Shariat SF

CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection.
Eur Urol. 2010;57: 648-54 [PDF]
Tilki D, Singer BB, Shariat SF, Behrend A, Fernando M, Irmak S, Buchner A, Hooper AT, Stief CG, Reich O, Ergün S

Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non-Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations.
Eur Urol. 2010;57: 607-14 [PDF]
Witjes JA, Redorta JP, Jacqmin D, Sofras F, Malmström PU, Riedl C, Jocham D, Conti G, Montorsi F, Arentsen HC, Zaak D, Mostafid AH, Babjuk M

Amiloride reduces portal hypertension in rat liver cirrhosis.
Gut. 2010;59(6): 827-36
Steib CJ, Hennenberg M, Beitinger F, Hartmann AC, Bystron M, De Toni EN, Gerbes AL

[Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib].
Hautarzt. 2010;61(8): 662-7
Wollenberg A, Staehler M, Eames T

Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.
Hepatology. 2010;51(6): 2086-96
Steib CJ, Bilzer M, op den Winkel M, Pfeiler S, Hartmann AC, Hennenberg M, Göke B, Gerbes AL

Vascular wall-resident stem cells.
Histol Histopathol. 2010;25(5): 681-9
Klein D, Hohn HP, Kleff V, Tilki D, Ergün S

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.
Hum Gene Ther. 2010;21(3): 285-97
Buchner A, Pohla H, Willimsky G, Frankenberger B, Frank R, Baur-Melnyk A, Siebels M, Stief CG, Hofstetter A, Kopp J, Pezzutto A, Blankenstein T, Oberneder R, Schendel DJ

Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma.
Int J Cancer. 2010;127(10): 2360-6
Ellinger J, Kahl P, Mertens C, Rogenhofer S, Hauser S, Hartmann W, Bastian PJ, Büttner R, Müller SC, von Ruecker A

Single-Phase Dual-Energy CT Allows for Characterization of Renal Masses as Benign or Malignant.
Invest Radiol. 2010; [Epub ahead of print]
Graser A, Becker CR, Staehler M, Clevert DA, Macari M, Arndt N, Nikolaou K, Sommer W, Stief C, Reiser MF, Johnson TR

The PolyScope: a modular design, semidisposable flexible ureterorenoscope system.
J Endourol. 2010;24(7): 1061-6
Bader MJ, Gratzke C, Walther S, Schlenker B, Tilki D, Hocaoglu Y, Sroka R, Stief CG, Reich O

Optimizing vesicourethral anastomosis healing after robot-assisted laparoscopic radical prostatectomy: lessons learned from three techniques in 1900 patients.
J Endourol. 2010;24(12): 1975-83
Tan G, Srivastava A, Grover S, Peters D, Dorsey P, Scott A, Jhaveri J, Tilki D, Te A, Tewari A

Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.
J Magn Reson Imaging. 2010;31(2): 490-501
Notohamiprodjo M, Sourbron S, Staehler M, Michaely HJ, Attenberger UI, Schmidt GP, Boehm H, Horng A, Glaser C, Stief C, Reiser MF, Herrmann KA

Anatomy, physiology, and pathophysiology of erectile dysfunction.
J Sex Med. 2010;7(1 Pt 2): 445-75
Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG

Summary of the recommendations on sexual dysfunctions in men.
J Sex Med. 2010;7(11): 3572-88
Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, Sharlip I, Althof SE, Andersson KE, Brock G, Broderick G, Burnett A, Buvat J, Dean J, Donatucci C, Eardley I, Fugl-Meyer KS, Goldstein I, Hackett G, Hatzichristou D, Hellstrom W, Incrocci L, Jackson G, Kadioglu A, Levine L, Lewis RW, Maggi M, McCabe M, McMahon CG, Montague D, Montorsi P, Mulhall J, Pfaus J, Porst H, Ralph D, Rosen R, Rowland D, Sadeghi-Nejad H, Shabsigh R, Stief C, Vardi Y, Wallen K, Wasserman M

Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction.
J Urol. 2010;184(2): 783-9
Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE

Editorial comment.
J Urol. 2010;183(1): 132
Gratzke C

Cannabinor, a Selective Cannabinoid-2 Receptor Agonist, Improves Bladder Emptying in Rats With Partial Urethral Obstruction.
J Urol. 2010; [Epub ahead of print]
Gratzke C, Streng T, Stief CG, Alroy I, Limberg BJ, Downs TR, Rosenbaum JS, Hedlund P, Andersson KE

Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats.
J Urol. 2010;184(5): 2197-204
Gratzke C, Strong TD, Gebska MA, Champion HC, Stief CG, Burnett AL, Bivalacqua TJ

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
J Urol. 2010;183(2): 460-6
Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A

Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
J Urol. 2010;183(6): 2165-70
Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, Lotan Y, Isbarn H, Capitanio U, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Tilki D, Dinney CP, Lerner SP, Schoenberg M, Volkmer BG, Sagalowsky AI, Shariat SF

Re: High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia A. Erol, K. Cam, A. Tekin, O. Memik, S. Coban And Y. Ozer J Urol 2009; 182: 1078-1082.
J Urol. 2010;183(2): 828-9; author reply 829-3
Rieken M, Bachmann A, Reich O

Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
J Urol. 2010;184(5): 1895-900
Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G

Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.
J Urol. 2010;183(1): 68-75
Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Lerner SP, Sagalowsky AI, Cote RJ, Lotan Y

Bladder dysfunction in a new mutant mouse model with increased superoxide--lack of nitric oxide?
J Urol. 2010;183(2): 780-5
Soler R, Füllhase C, Lu B, Bishop CE, Andersson KE

Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer.
J Urol. 2010; [Epub ahead of print]
Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.
J Urol. 2010;184(5): 1907-13
Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB

Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
J Urol. 2010;183(5): 1757-63
Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF

pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
J Urol. 2010;184(2): 470-4
Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Ficarra V, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF

Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
J Urol. 2010;183(1): 87-93
Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF

Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
J Urol. 2010;184(3): 888-94 (Impact(2009)=4.016, Typ=Journal Article; Multicenter Study; Comparative Study)
Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF

TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation.
J Urol. 2010;183(5): 2070-6
Weinhold P, Gratzke C, Streng T, Stief C, Andersson KE, Hedlund P

Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma.
J Urol. 2010;184(5): 1888-94
Winter H, Meimarakis G, Angele MK, Hummel M, Staehler M, Hoffmann RT, Hatz RA, Löhe F

Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis.
Lab Invest. 2010;90(7): 1024-32
Steib CJ, Hartmann AC, v Hesler C, Benesic A, Hennenberg M, Bilzer M, Gerbes AL

[Therapeutic options in localized prostate cancer].
MMW Fortschr Med. 2010;152(19): 43-4
Bastian PJ

[Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
MMW Fortschr Med. 2010;152(19): 36
Bastian PJ, Stief CG

[Emergency checklist: priapism]
MMW Fortschr Med. 2010;152(6): 41
Nuhn P, Stief CG

[Emergency checklist: Acute urinary retention]
MMW Fortschr Med. 2010;152(12): 43
Nuhn P, Stief CG

[Emergency checklist: macroscopic hematuria].
MMW Fortschr Med. 2010;152(28-30): 43
Nuhn P, Stief ChG

[Diagnosis of prostate cancer].
MMW Fortschr Med. 2010;152(19): 40-2
Strittmatter F

MMW Fortschr Med. 2010;152(16): 42-5; quiz 46
Walther S, Hilburger M, Bader MJ, Stief CG, Strittmatter F

Bladder cancer: Nomogram aids clinical decision making after radical cystectomy.
Nat Rev Urol. 2010;7(4): 182-4
Shariat SF, Tilki D

Vascular therapy for radiation cystitis.
Neurourol Urodyn. 2010; [Epub ahead of print]
Soler R, Vianello A, Füllhase C, Wang Z, Atala A, Soker S, Yoo JJ, Koudywilliam J

Profile of temsirolimus in the treatment of advanced renal cell carcinoma.
Onco Targets Ther. 2010;3: 191-6
Staehler M, Haseke N, Khoder W, Stief CG

The prognostic value of cadherin switch in bladder cancer.
Oncol Rep. 2010;23(4): 1125-32
Jäger T, Becker M, Eisenhardt A, Tilki D, Tötsch M, Schmid KW, Romics I, Rübben H, Ergün S, Szarvas T

Current status of ultrasound imaging in prostate cancer.
Panminerva Med. 2010;52(3): 189-94
Seitz M, Strittmatter F, Roosen A, Tilki D, Gratzke C

Comment on "Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle-invasive bladder cancer" by Lui Shiong Lee et al. [Photodiagn Photodyn Ther 2010;7:213-20].
Photodiagnosis Photodyn Ther. 2010;7(4): 221
Waidelich R

Global levels of histone modifications predict prostate cancer recurrence.
Prostate. 2010;70(1): 61-9
Ellinger J, Kahl P, von der Gathen J, Rogenhofer S, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Büttner R, Müller SC, Bastian PJ, von Ruecker A

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome.
Urol Int. 2010; [Epub ahead of print]
Bauer RM, Gratzke C, Roosen A, Hocaoglu Y, Mayer ME, Buchner A, Stief CG, May F

Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardial decompensation with sunitinib malate therapy.
Urol Int. 2010;84(1): 119-21
Staehler M, Haseke N, Zilinberg K, Stadler T, Stief CG

Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies.
Urol Oncol. 2010; [Epub ahead of print]
Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G

Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Urol Oncol. 2010; [Epub ahead of print]
Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF

Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention.
Urol Oncol. 2010;28(2): 139-44
Staehler M, Haseke N, Zilinberg E, Stadler T, Karl A, Siebels M, Dürr HR, Siegert S, Jauch KW, Bruns CJ, Stief CG

Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.
Urol Oncol. 2010; [Epub ahead of print]
Staehler M, Haseke N, Stadler T, Nuhn P, Roosen A, Stief CG, Wilkowski R

Efficacy of retrograde ureteropyeloscopic holmium laser lithotripsy for intrarenal calculi >2 cm.
Urol Res. 2010; [Epub ahead of print]
Bader MJ, Gratzke C, Walther S, Weidlich P, Staehler M, Seitz M, Sroka R, Reich O, Stief CG, Schlenker B

[Prostatic inflammation and prostate cancer]
Urologe A. 2010;49(5): 636-8
Bastian PJ, Nuhn P, Stadler TC, Roosen A, Stief CG

[Epidermoid cyst of the kidney : a rare cause of recurrent renal colic]
Urologe A. 2010;49(4): 540-2
Bauer RM, Siegert S, Nordhaus C, Staehler M

[Diagnostic algorithm in cystic renal masses]
Urologe A. 2010;49(3): 421-31; quiz 432
Clevert DA, Horng A, Staehler M, Haseke N, Stief C, Reiser M

[Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies].
Urologe A. 2010;49(9): 1131-2, 1134
Ellinger J, von Rücker A, Bastian PJ, Müller SC

[Diagnostic procedure for bladder cancer. Standards and current developments].
Urologe A. 2010;49(10): 1303-11; quiz 1312
Karl A, Tritschler S, Zaak D, Tilki D, Stief C, Burger M

[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens].
Urologe A. 2010;49(12): 1508-15
May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Bastian PJ

[Benign prostatic hyperplasia (BPH) : Surgical therapy options]
Urologe A. 2010;49(1): 113-26
Reich O, Seitz M, Gratzke C, Schlenker B, Walther S, Stief C

[Diagnostic work-up for lymph node metastases of urological tumors]
Urologe A. 2010;49(3): 356-63
Seitz M, Bader M, Strittmatter F, Gratzke C, Tilki D, Roosen A, Schlenker B, Reich O, Stief C

[Pyrosequencing in uro-oncology: applications in prostate cancer].
Urologe A. 2010;49(11): 1356-64
Stadler TC, Jung A, Schlenker B, Nuhn P, Ellinger J, Kirchner T, Stief CG, Bastian PJ

[Systemic therapy of renal cell carcinoma].
Urologe A. 2010;49(12): 1543-50; quiz 1551
Staehler M, Tüllmann C, Nuhn P, Haseke N, Stief CG

[Clinical approach to renal trauma].
Urologe A. 2010;49(7): 837-41
Staehler M, Nuhn P, Haseke N, Tüllmann C, Bader M, Graser A, Stief CG

[Laboratory work-up of testosterone]
Urologe A. 2010;49(1): 11-5
Trottmann M, Dickmann M, Stief CG, Becker AJ

Complications of the AdVance transobturator male sling in the treatment of male stress urinary incontinence.
Urology. 2010;75(6): 1494-8
Bauer RM, Mayer ME, May F, Gratzke C, Buchner A, Soljanik I, Bastian PJ, Stief CG, Gozzi C

Results of the AdVance Transobturator Male Sling After Radical Prostatectomy and Adjuvant Radiotherapy.
Urology. 2010; [Epub ahead of print]
Bauer RM, Soljanik I, Füllhase C, Buchner A, May F, Stief CG, Gozzi C

Downregulation of HNF-1B in Renal Cell Carcinoma Is Associated With Tumor Progression and Poor Prognosis.
Urology. 2010; [Epub ahead of print]
Buchner A, Castro M, Hennig A, Popp T, Assmann G, Stief CG, Zimmermann W

Urinary Cytology in Era of Fluorescence Endoscopy: Redefining the Role of an Established Method With a New Reference Standard.
Urology. 2010; [Epub ahead of print]
Tritschler S, Sommer ML, Straub J, Hocaoglu Y, Tilki D, Strittmatter F, Zaak D, Stief C, Karl A

Potential mechanism of action of human growth hormone on isolated human penile erectile tissue.
Urology. 2010;75(4): 968-73
Ückert S, Scheller F, Stief CG, Knapp WH, Sohn M, Becker AJ, Kuczyk MA

Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4.
Urology. 2010;76(2): 515.e8-14
Waldkirch E, Uckert S, Sigl K, Langnaese K, Richter K, Stief CG, Kuczyk MA, Hedlund P

Ho:YAG-laser: treatment of vesicourethral strictures after radical prostatectomy.
World J Urol. 2010;28(2): 169-72
Bader MJ, Tilki D, Gratzke C, Sroka R, Stief CG, Reich O

Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.
World J Urol. 2010; [Epub ahead of print]
Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G

A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX((R))) and interferon-alpha-2a in metastatic renal cell carcinoma patients.
World J Urol. 2010; [Epub ahead of print]
Siebels M, Rohrmann K, Oberneder R, Stahler M, Haseke N, Beck J, Hofmann R, Kindler M, Kloepfer P, Stief C

Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis.
World J Urol. 2010; [Epub ahead of print]
Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ

Photodynamic diagnosis in patients with T1G3 bladder cancer: influence on recurrence rate.
World J Urol. 2010;28(4): 407-11
Stanislaus P, Zaak D, Stadler T, Tritschler S, Knüchel R, Stief CG, Karl A